Edwards Lifesciences Corp [NYSE: EW] jumped around 1.8 points on Thursday, while shares priced at $85.78 at the close of the session, up 2.14%.
Edwards Lifesciences Corp stock is now 21.62% up from its year-to-date (YTD) trading value. EW Stock saw the intraday high of $85.96 and lowest of $83.98 per share. The company’s 52-week high price is 87.40, which means current price is +30.09% above from all time high which was touched on 11/26/25.
Compared to the average trading volume of 4.49M shares, EW reached a trading volume of 3612555 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Edwards Lifesciences Corp [EW]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EW shares is $95.59 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EW stock is a recommendation set at 1.89. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Raymond James have made an estimate for Edwards Lifesciences Corp shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on November 03, 2025. The new note on the price target was released on October 29, 2025, representing the official price target for Edwards Lifesciences Corp stock. Previously, the target price had yet another raise to $98, while Jefferies analysts kept a Buy rating on EW stock.
The Price to Book ratio for the last quarter was 4.88, with the Price to Cash per share for the same quarter was set at 6.62. Price to Free Cash Flow for EW in the course of the last twelve months was 61.90 with Quick ratio for the last quarter at 3.29.
How has EW stock performed recently?
Edwards Lifesciences Corp [EW] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.12. With this latest performance, EW shares gained by 1.94% in over the last four-week period, additionally plugging by 10.30% over the last 6 months – not to mention a rise of 15.87% in the past year of trading.
Edwards Lifesciences Corp [EW]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Edwards Lifesciences Corp [EW] shares currently have an operating margin of 27.23% and a Gross Margin at 77.90%. Edwards Lifesciences Corp’s Net Margin is presently recorded at 23.48%.
Edwards Lifesciences Corp (EW) Capital Structure & Debt Analysis
According to recent financial data for Edwards Lifesciences Corp. ( EW), the Return on Equity (ROE) stands at 13.59%, reflecting robust shareholder value creation. The Return on Assets (ROA) is 10.23%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Edwards Lifesciences Corp’s Return on Invested Capital (ROIC) is 12.70%, showcasing its effectiveness in deploying capital for earnings.
Edwards Lifesciences Corp (EW) Efficiency & Liquidity Metrics
Based on Edwards Lifesciences Corp’s (EW) latest financial statements, the Debt-to-Equity Ratio is 0.07%, indicating its reliance on debt financing relative to shareholder equity.
Edwards Lifesciences Corp (EW) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Edwards Lifesciences Corp. (EW) effectively leverages its workforce, generating an average of $87341.77 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.00% and a Quick Ratio of 3.29%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Edwards Lifesciences Corp [EW]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EW. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Edwards Lifesciences Corp go to 9.83%.
Insider trade positions for Edwards Lifesciences Corp [EW]
There are presently around $90.05%, or 90.89%% of EW stock, in the hands of institutional investors. The top three institutional holders of EW stocks are: VANGUARD GROUP INC with ownership of 53.58 million shares, which is approximately 8.8982%. BLACKROCK INC., holding 50.98 million shares of the stock with an approximate value of $$4.71 billion in EW stocks shares; and BLACKROCK INC., currently with $$2.4 billion in EW stock with ownership which is approximately 4.3197%.
